Managing heart failure better: the value of implantable device data.
The heart failure disease state is challenging, time consuming and expensive to manage. Physicians are responsible for initiating, titrating and optimizing drug and device therapy to reduce morbidity and mortality. Failure to manage these aspects of care often results in worsening of symptoms and recurrent hospitalizations. This paper reviews the data implantable devices provide and how this data can assist in optimally managing the patient with heart failure.
Best
John F
JF
Department of Internal Medicine, University of Missouri, USA. BestJ@health.missouri.edu
Feldker
Helen
H
Aggarwal
Kul
K
Tejwani
Lokesh
L
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000368:Aged; D001281:Atrial Fibrillation / Q000628:therapy; D017147:Defibrillators, Implantable; D005260:Female; D006333:Heart Failure / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D010349:Patient Compliance; D014882:Water-Electrolyte Balance / Q000502:physiology
D000319:Adrenergic beta-Antagonists